We're really trying to change societal narrative about this topic without it being polarizing
In July 2024, researchers at Mass Eye and Ear published a landmark study in JAMA Ophthalmology linking semaglutide to a significantly elevated risk of nonarteritic anterior ischemic optic neuropathy (NAION) - a condition that can cause sudden, irreversible partial or total vision loss in one eye
Judith Aniekwena, double board-certified in obesity and internal medicine, are committed to delivering GLP-1 treatment that is safe, effective, and customized to your health needs
PlexusDx patients beginning semaglutide therapy should discuss baseline nutrient screening with their provider to create a personalized supplementation plan
The trade-off is that 1mg and 2mg doses become very small volumes (10 and 20 units respectively), where measurement precision on cheaper syringes can be questionable
4.5 1.0 h) and slower clearance (1.9 0.5 L/h/kg vs